Randomized comparative study for the assessment of a new therapeutic schedule of fosfomycin trometamol in postmenopausal women with uncomplicated lower urinary tract infection;Estudio comparativo aleatorizado para la evaluación de un nuevo esquema terapéutico de fosfomicina trometamol en mujeres posmenopáusicas con infección no complicada del tracto urinario inferior

Actas Urologicas Espanolas

Volumn 37, Issue 3, 2013, Pages 147-155

  Palou, J ^a   Angulo, J C ^b   Ramon De Fata F ^b   Garcia Tello A ^b   Gonzalez Enguita C ^c   Boada, A ^d   Sanz, M ^e  

^a FUNDACIÓ PUIGVERT   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^d Centro de Atención Primaria Casanova   (Spain)

^e Centro de Salud Las Aguilas   (Spain)

Author keywords

Ciprofloxacin; Fosfomycin trometamol; Postmenopausal; Urinary infection

Indexed keywords

ANTIINFECTIVE AGENT; CIPROFLOXACIN; FOSFOMYCIN;

AGED; ARTICLE; BACTERIAL INFECTION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; HUMAN; MULTICENTER STUDY; POSTMENOPAUSE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; URINARY TRACT INFECTION;

AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CIPROFLOXACIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOSFOMYCIN; HUMANS; POSTMENOPAUSE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; URINARY TRACT INFECTIONS;

EID: 84875228895     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2012.06.007     Document Type: Article

References (36)

1. T.M. Hooton Pathogenesis of urinary tract infections: an update J Antimicrob Chemother 46 Suppl. 1 2000 S1 S7
2. K.G. Naber, G. Schito, H. Botto, J. Palou, and T. Mazzei Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): Implications for empiric therapy Eur Urol 54 2008 1164 1175
3. G.C. Schito, K.G. Naber, H. Botto, J. Palou, T. Mazzei, and L. Gualco The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections Int J Antimicrob Agents 34 2009 407 413
4. J. Palou, C. Pigrau, I. Molina, J.M. Ledesma, J. Angulo Grupo Colaborador Español del Estudio ARESC Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC Study): implications on empiric therapy Med Clin (Barc) 136 2011 1 7
5. A. Andreu, and I. Planells Grupo Cooperativo Español para el Estudio de la Sensibilidad Antimicrobiana de los Patógenos Urinarios Med Clin (Barc) 130 2008 481 486
6. J.W. Warren, E. Abrutyn, R. Hebel, J.R. Johnson, A.J. Schaeffer, and W.E. Stamm Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women Clin Infect Dis 29 1999 745 758
7. A. Marchese, L. Gualco, E.A. Debbia, G.C. Schito, and A.M. Schito In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance Int J Antimicrob Agents 22 Suppl. 2 2003 S53 S59
8. B.J. Knottnerus, S. Nys, G. ter Riet, G. Donker, S.E. Geerlings, and E. Stobberingh Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands? J Antimicrob Chemother 62 2008 356 359
9. A. Andreu, J.I. Alos, M. Gobernado, F. Marco, M. de la Rosa, J.A. García-Rodríguez Grupo Cooperativo Español para el Estudio de la Sensibilidad Antimicrobiana de los Patógenos Urinarios Enferm Infecc Microbiol Clin 23 2005 4 9
10. K. Gupta, T.M. Hooton, K.G. Naber, B. Wullt, R. Colgan, L.G. Miller Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases International Clinical Practice Guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases Clin Infect Dis 52 2011 103 120
11. M. Grabe, T.E. Bjerklund-Johansen, H. Botto, B. Wullt, M. Çek, and K.G. Naber Guidelines on Urological Infections European Association of Urology 2012 Disponible en: http://www.uroweb.org
12. D. Tena, A. González-Praetorius, J.C. González, E. Heredero, S. Illescas, and C. Sáinz de Baranda Evolución del patrón de sensibilidad de Escherichia coli en infecciones del tracto urinario diagnosticadas en la comunidad durante el periodo 2003-2007. Estudio multicéntrico en Castilla la Mancha Rev Esp Quimioter 23 2010 36 42
13. M. Gobernado, L. Valdés, J.I. Alós, C. García-Rey, R. Dal-Ré, J. García-de-Lomas the Spanish Surveillance Group for Urinary Pathogens Antimicobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain Rev Esp Quimioter 20 2007 68 76
14. C. Llor, C. Aspiroz, A. Cano, and M. Barranco Debería revisarse la utilización de amoxicilina y ácido clavulánico y quinolonas como antibióticos de primera elección en las infecciones no complicadas del tracto urinario Atención Primaria 44 2012 443 444
15. B. Sádaba, J.R. Azanza, E. García-Quetglas, and J. Honorato Fosfomicina trometamol. Dosis múltiples como pauta larga en el tratamiento de las infecciones urinarias bajas. Enfermedades Infecciosas y Microbiología Clínica Enferm Infecc Microbiol Clin 24 2006 546 550
16. Milo G, Katchman EA, Paul M, Christiaens T, Baerheim A, Leibovici I. Duración del tratamiento antibacteriano para la infección urinaria no complicada en mujeres. La Biblioteca Cochrane Plus, 2008 Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com (Traducida de: The Cochrane Library, 2008 Issue 3. Chichester, UK: John Wiley & Sons, Ltd.)
17. A.D. Tice Short-course therapy of acute cystitis: a brief review of therapeutic strategies J Antimicrob Chem 43 Suppl. A 1999 S85 S93
18. A. Iravani, A.D. Tice, J. McCarty, D.H. Sikes, T. Nolen, and H.A. Gallis Short course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected] Arch Intern Med 155 1995 485 494
19. A. Iravani, I. Klimberg, C. Briefer, C. Munera, S.F. Kowalsky, and R.M. Echols A trial comparing low-dose, short-course ciprofloxacin and standard 7-day therapy with co-trimoxaazole or nitrofurantoin in the treatment of uncomplicated Urinary Tract Infection J Antimicrob Chemother 43 Suppl. A 1999 S67 S75
20. E.A. Katchman, G. Milo, M. Paul, T. Chritiaens, A. Baerheim, and L. Leibovici Three-day vs longer duration of antibiotic treatment for cystitis in women: systemic review and meta-analysis Am Journal Med 118 2005 1196 1207
21. A. Jardin A general practitioner multicenter study: fosfomycin trometamol single dose versus pipemidic acid multiple dose Infection 18 Suppl. 2 1990 S89 S93
22. L.M. Shortliffe, and J.D. McCue Urinary tract infection at the age extremes: pediatrics and geriatrics Am J Med 113 Suppl. 1A 2002 S55 S66
23. Lutters M, Vogt N. Duración del tratamiento antibiótico para las infecciones urinarias bajas sintomáticas no complicadas en ancianas. Biblioteca Cochrane Plus, 2006, N° 1.
24. L.A. Beveridge, P.G. Davey, G. Phillips, and M.E. McMurdo Optimal management of urinary tract infections in older people Clin Interv Aging 6 2011 173 180
25. R. Raz, and S. Rozenfeld 3-day course of ofloxacin versus cefalexin in the treatment of urinary tract infections in postmenopausal women Antimicrob Agents Chemother 40 1996 2200 2201
26. T. Vogel, R. Verreault, M. Gourdeau, M. Morin, L. Grenier-Gosselin, and L. Rochette Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial CMAJ 170 2004 469 473
27. G. Ferraro, L. Ambrosi, R. Bucci, and G. Palmieri Fosfomycin trometamol versus Norfloxacin in the treatment of uncomplicated lower urinary tract infections in the elderly Chemotherapy 36 Suppl. 1 1990 S46 S49
28. J. Guibert, M.H. Capron, and A. Giacomino Treatment of non-complicated acute cystitis in women: lomefloxacin versus pefloxacin Presse Med 25 1996 1271 1275
29. J. Guibert, E. Mazeman, J.C. Colau, and P. Delavault Acute cystitis in women over 50 years of age. Efficacy of pefloxacin with single dose and norfloxacin for 10 days Presse Med 22 1993 288 292
30. M.A. Miniassian, D.A. Kewis, D. Chattopadhyay, B. Bovill, G.J. Duckworth, and J.D. Williams A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women Int J Antimicrob Agents 10 1998 39 47
31. N. Ceran, D. Mert, F.Y. Kocdogan, I. Erdem, R. Adalati, and S. Ozyurek A randomized comparative study of single-dose fosfomycin and 5-day cuprofloxacin in female patients with uncomplicated lower urinary tract infections J Infect Chemother 16 2010 424 430
32. S.S. Patel, S.A. Balfour, and H.M. Bryson Fosfomycin tromethamine: a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections Drugs 53 1997 637 656
33. D. Ungheri, E. Albini, and G. Belluco In vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol J Chemother 14 2001 237 240
34. M. de Cueto, J.R. Hernández, L. López-Cerero, C. Morillo, and A. Pascual Actividad de fosfomicina sobre cepas de Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido Enferm Infecc Microbiol Clin 24 2006 613 616
35. J. Rodríguez-Baño, J.C. Alcalá, J.M. Cisneros, F. Grill, A. Oliver, and J.P. Horcajada Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli Arch Intern Med 168 2008 1897 1902
36. M. Gobernado, L. Valdés, J.I. Alós, C. García-Rey, R. Dal-Ré, J. García-de-Lomas Spanish Surveillance Group for Urinary Pathogens Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences Rev Esp Quimioter 20 2007 206 210